Loading...

Advanced Digital Health And Infection Control Will Drive Future Markets

Published
17 Dec 24
Updated
21 Sep 25
AnalystConsensusTarget's Fair Value
SEK 235.71
14.5% undervalued intrinsic discount
21 Sep
SEK 201.50
Loading
1Y
-7.4%
7D
-4.4%

Author's Valuation

SEK 235.71

14.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on21 Sep 25
Fair value Increased 3.04%

The consensus Price Target for Getinge has increased despite a significant rise in future P/E and a notable decline in net profit margin, now standing at SEK235.71. What's in the News Getinge AB (publ) has been dropped from the OMX Stockholm 30 Index.

Shared on05 Sep 25

As both the discount rate and future P/E for Getinge showed only marginal movements, analysts maintained an unchanged consensus price target of SEK228.75. What's in the News Getinge AB (publ) has been removed from the OMX Stockholm 30 Index.

Shared on01 May 25
Fair value Decreased 4.95%

Shared on23 Apr 25
Fair value Decreased 3.32%

AnalystConsensusTarget has decreased revenue growth from 5.0% to 4.1%.

Shared on17 Apr 25
Fair value Decreased 1.02%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 6.92%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 4.30%

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 2.60%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.